Immediate Impact

52 standout
Sub-graph 1 of 25

Citing Papers

The first MASH drug therapy on the horizon: Current perspectives of resmetirom
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
2 intermediate papers

Works of Ayaskanta Singh being referenced

Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case–Control Study
2015

Author Peers

Author Last Decade Papers Cites
Ayaskanta Singh 156 65 80 40 306
Miguel Malespin 168 73 117 33 315
Carlos Fernández‐Carrillo 204 63 179 29 348
Tokunbo Ajayi 127 137 90 23 327
Patrick Basu 155 136 95 56 349
Xing Yang 130 25 25 35 303
Danielle Roberts 109 47 82 29 329
Abhinav Anand 190 121 130 44 341
Yunkoo Kang 120 53 37 39 257
Fatih Ermış 104 90 66 32 312
Sunil Pawar 88 81 35 30 257

All Works

Loading papers...

Rankless by CCL
2026